PRKN

PRKN

Target · E3 ubiquitin ligase

PRKN Parkin RBR E3 ubiquitin protein ligase · E3 ubiquitin-protein ligase parkin

PRKN (parkin RBR E3 ubiquitin protein ligase, also known as parkin, PARK2, PDJ and AR-JP) encodes an E3 ubiquitin-protein ligase that attaches ubiquitin to substrate proteins. It acts downstream of PINK1 in mitochondrial quality control, and mutations in the gene cause Parkinson disease. Browse Assay Genie's current range of PRKN research reagents below, or read on for the biology behind the target.

Cytosol and mitochondrionRBR E3 ubiquitin ligaseMutated in Parkinson disease
465 aa
Protein length
~52 kDa
Molecular weight
6q26
Gene locus
EC 2.3.2.31
Enzyme class
Target information

What is PRKN (parkin RBR E3 ubiquitin protein ligase)?

PRKN functions within a multiprotein E3 ubiquitin ligase complex, catalysing the covalent attachment of ubiquitin to substrate proteins. Depending on context it mediates monoubiquitination or polyubiquitination through Lys-6, Lys-11, Lys-48 and Lys-63 linkages. Substrates include SYT11, VDAC1, BCL2, CCNE1, GPR37, MFN1, MFN2, TOMM20, USP30, ZNF746 and RHOT1/MIRO1. Lys-63-linked polyubiquitination of misfolded proteins such as PARK7 marks them for recognition by HDAC6 and recruitment to aggresomes before degradation.

Its best-characterised role is in protecting against mitochondrial dysfunction during cellular stress. Recruitment to the outer membrane of damaged mitochondria and activation of parkin require PINK1-mediated phosphorylation of both PRKN and ubiquitin. Depending on the severity of damage, the PINK1-PRKN pathway can prevent apoptosis, stimulate mitochondrial biogenesis, regulate mitochondrial dynamics or eliminate badly damaged mitochondria by mitophagy. Polyubiquitination of VDAC1 promotes mitophagy, whereas monoubiquitination decreases mitochondrial calcium influx and inhibits apoptosis. Parkin also promotes degradation of MFN2 and MIRO1, which prevents refusion and limits transport of damaged mitochondria, and it drives degradation of ZNF746/PARIS to allow PPARGC1A activation. Independently of ligase activity, it represses TP53 transcription. It may also protect neurons against alpha-synuclein toxicity and excitotoxicity, and may influence neurotransmitter trafficking at the presynapse.

The PRKN gene belongs to the ring finger and RBR E3 ubiquitin ligase groups, and the protein is a member of the parkin subfamily of the RBR family. UniProt records it in the cytosol, nucleus, endoplasmic reticulum, mitochondrial outer membrane, neuron projections, postsynaptic density and presynapse. Mutations in PRKN cause Parkinson disease, including autosomal recessive juvenile Parkinson disease, which explains the earlier gene name Parkinson disease (autosomal recessive, juvenile) 2. Alternative splicing produces multiple transcript variants encoding distinct isoforms, and the gene may also act as a tumour suppressor.

Parkinson disease research

Mutations in the PRKN gene cause Parkinson disease and autosomal recessive juvenile Parkinson disease, making parkin central to studies of disease mechanism.

Mitophagy and mitochondrial quality

Parkin acts downstream of PINK1 to ubiquitinate mitochondrial proteins and eliminate severely damaged, depolarised mitochondria by mitophagy.

Ubiquitin signalling studies

Parkin builds monoubiquitin and Lys-6, Lys-11, Lys-48 and Lys-63-linked chains, a useful model for context-dependent E3 ligase activity.

Neuroprotection and cell stress

Parkin may protect neurons against alpha-synuclein toxicity, proteasomal dysfunction and excitotoxicity, and limits reactive oxygen species production.

Background

PRKN frequently asked questions

What does PRKN do?

PRKN is an E3 ubiquitin ligase that transfers ubiquitin to substrate proteins. Together with PINK1 it ubiquitinates proteins on damaged mitochondria, directing outcomes from preventing apoptosis to mitophagy. It also targets misfolded proteins to aggresomes and helps control mitochondrial biogenesis and motility.

What other names does PRKN go by?

PRKN is also called parkin, PARK2, PDJ and AR-JP. Earlier names include Parkinson disease (autosomal recessive, juvenile) 2, parkin, and parkinson protein 2, E3 ubiquitin protein ligase (parkin). Alternative splicing yields multiple transcript variants encoding distinct isoforms.

Is PRKN linked to disease and conserved in rodents?

Mutations in PRKN are known to cause Parkinson disease, including autosomal recessive juvenile Parkinson disease. Mouse and rat both carry a Prkn ortholog. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Mitophagy regulators, parkin substrates and Parkinson disease-associated proteins that work alongside PRKN.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O60260; product specifications from Assay Genie datasheets.

PRKN Product listing